Perspective Therapeutics Inc

XASE:CATX

4.07

-0.15 (-3.56%)

7:55:44 PM EDT: $4.15 +0.08 (+1.97%)

Market Cap (Intraday)	447.20M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.16 Million
Adjusted EPS	-$0.29

See more estimates

10-Day MA	$4.49
50-Day MA	$4.51
200-Day MA	$3.57

See more pivots

Perspective Therapeutics Inc Stock, XASE:CATX

2401 Elliott Avenue, Suite 320, Seattle, Washington 98121

United States of America

Phone: +1.206.676.0900

Number of Employees: 119

http://perspectivetherapeutics.com

Description

Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1983 and is headquartered in Seattle, WA.